Post‒COVID-19 Condition Treatment and Management Rapid Scoping Review

Key Messages

• This rapid living scoping review provides an up-to-date map of the latest published evidence, and identifies research gaps regarding the treatment and management for post–COVID-19 condition.
• Most of the included studies were from a few countries, particularly the US, the UK, and Canada. Also, most of the studies were case reports or series, meaning they included few participants.
• Most of the identified published research on treatments for post‒COVID-19 condition focused on:
  • vaccines administered 3 months after initial infection
  • pharmacological interventions for cardiovascular, neurological, and pulmonary symptoms and diagnoses
  • non-pharmacological interventions for pulmonary symptoms.
• There were fewer studies related to other types of symptoms and organ systems.
• There were notable evidence gaps across all treatments for post–COVID-19 condition, as noted by most of the evidence being from case reports, in which physicians may more often report patients with uncommon symptoms or diagnoses.